...
veru-img

Veru Inc, Common Stock

VERU

NAQ

$0.67

-$0.04

(-5.61%)

1D
Industry: Personal Care Products Sector: Consumer Staples

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$104.42M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.34M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.36 L
$1.92 H
$0.67

About Veru Inc, Common Stock

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. more

Industry: Personal Care ProductsSector: Consumer Staples

Returns

Time FrameVERUSectorS&P500
1-Week Return-0.96%-1.42%0.2%
1-Month Return20.86%1.18%2.72%
3-Month Return-8.91%-2.38%7.31%
6-Month Return-14.26%4.88%10.44%
1-Year Return4.91%14.04%27.53%
3-Year Return-88.75%8.34%30.88%
5-Year Return-75.15%29.52%89.21%
10-Year Return-81.71%69.38%199.95%

Financials

Sep '20Sep '21Sep '22Sep '23Sep '245YR TREND
Total Revenue42.59M61.26M39.35M16.30M16.89M[{"date":"2020-09-30","value":69.53,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":64.24,"profit":true},{"date":"2023-09-30","value":26.6,"profit":true},{"date":"2024-09-30","value":27.57,"profit":true}]
Cost of Revenue11.81M13.33M8.76M8.73M11.03M[{"date":"2020-09-30","value":88.55,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":65.73,"profit":true},{"date":"2023-09-30","value":65.49,"profit":true},{"date":"2024-09-30","value":82.75,"profit":true}]
Gross Profit30.79M47.93M30.59M7.57M5.85M[{"date":"2020-09-30","value":64.24,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":63.83,"profit":true},{"date":"2023-09-30","value":15.79,"profit":true},{"date":"2024-09-30","value":12.21,"profit":true}]
Gross Margin72.28%78.24%77.73%46.43%34.67%[{"date":"2020-09-30","value":92.39,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":99.36,"profit":true},{"date":"2023-09-30","value":59.34,"profit":true},{"date":"2024-09-30","value":44.31,"profit":true}]
Operating Expenses45.53M53.36M113.81M103.11M43.99M[{"date":"2020-09-30","value":40.01,"profit":true},{"date":"2021-09-30","value":46.89,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":90.59,"profit":true},{"date":"2024-09-30","value":38.65,"profit":true}]
Operating Income(14.75M)(5.44M)(83.22M)(93.72M)(38.14M)[{"date":"2020-09-30","value":-1474669400,"profit":false},{"date":"2021-09-30","value":-543750100,"profit":false},{"date":"2022-09-30","value":-8322356000,"profit":false},{"date":"2023-09-30","value":-9371847700,"profit":false},{"date":"2024-09-30","value":-3813830500,"profit":false}]
Total Non-Operating Income/Expense(9.93M)(13.59M)(4.68M)2.93M-[{"date":"2020-09-30","value":-338.41,"profit":false},{"date":"2021-09-30","value":-463.41,"profit":false},{"date":"2022-09-30","value":-159.71,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Pre-Tax Income(20.05M)4.27M(83.54M)(92.61M)(37.08M)[{"date":"2020-09-30","value":-470.13,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1958.62,"profit":false},{"date":"2023-09-30","value":-2171.25,"profit":false},{"date":"2024-09-30","value":-869.27,"profit":false}]
Income Taxes(1.08M)(3.13M)236.40K480.21K725.10K[{"date":"2020-09-30","value":-148.73,"profit":false},{"date":"2021-09-30","value":-431.55,"profit":false},{"date":"2022-09-30","value":32.6,"profit":true},{"date":"2023-09-30","value":66.23,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Income After Taxes(18.97M)7.39M(83.78M)(93.09M)-[{"date":"2020-09-30","value":-256.59,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1258.92,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Income From Continuous Operations(18.97M)7.39M(83.78M)(93.09M)-[{"date":"2020-09-30","value":-256.59,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1258.92,"profit":false},{"date":"2024-09-30","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income(18.97M)7.39M(83.78M)(93.09M)(37.80M)[{"date":"2020-09-30","value":-256.59,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1258.92,"profit":false},{"date":"2024-09-30","value":-511.22,"profit":false}]
EPS (Diluted)(0.08)(0.14)(1.05)(1.19)(0.28)[{"date":"2020-09-30","value":-8,"profit":false},{"date":"2021-09-30","value":-14,"profit":false},{"date":"2022-09-30","value":-105,"profit":false},{"date":"2023-09-30","value":-119,"profit":false},{"date":"2024-09-30","value":-28.2,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VERU
Cash Ratio 2.74
Current Ratio 3.62
Quick Ratio 3.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VERU
ROA (LTM) -64.36%
ROE (LTM) -126.72%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VERU
Debt Ratio Lower is generally better. Negative is bad. 0.42
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VERU
Trailing PE NM
Forward PE 117.65
P/S (TTM) 7.41
P/B 3.23
Price/FCF NM
EV/R 5.53
EV/Ebitda NM
PEG NM

FAQs

What is Veru Inc share price today?

Veru Inc (VERU) share price today is $0.67

Can Indians buy Veru Inc shares?

Yes, Indians can buy shares of Veru Inc (VERU) on Vested. To buy Veru Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VERU stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Veru Inc be purchased?

Yes, you can purchase fractional shares of Veru Inc (VERU) via the Vested app. You can start investing in Veru Inc (VERU) with a minimum investment of $1.

How to invest in Veru Inc shares from India?

You can invest in shares of Veru Inc (VERU) via Vested in three simple steps:

  • Click on Sign Up or Invest in VERU stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Veru Inc shares
What is Veru Inc 52-week high and low stock price?

The 52-week high price of Veru Inc (VERU) is $1.92. The 52-week low price of Veru Inc (VERU) is $0.36.

What is Veru Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Veru Inc (VERU) is

What is Veru Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Veru Inc (VERU) is 3.23

What is Veru Inc dividend yield?

The dividend yield of Veru Inc (VERU) is 0.00%

What is the Market Cap of Veru Inc?

The market capitalization of Veru Inc (VERU) is $104.42M

What is Veru Inc’s stock symbol?

The stock symbol (or ticker) of Veru Inc is VERU

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top